Hubei Guangji Pharmaceutical Co Ltd Asset Resilience Ratio
Hubei Guangji Pharmaceutical Co Ltd asset resilience ratio. Hubei Guangji Pharmaceutical Co Ltd (000952) has an Asset Resilience Ratio of 5.37% as of September 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000952 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Hubei Guangji Pharmaceutical Co Ltd (1999–2011)
Asset resilience ratio of Hubei Guangji Pharmaceutical Co Ltd from 1999 to 2011. This chart shows how Hubei Guangji Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 000952 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Hubei Guangji Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 000952 total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥110.00 Million | 5.37% |
| Total Liquid Assets | CN¥110.00 Million | 5.37% |
Asset Resilience Insights
- Limited Liquidity: Hubei Guangji Pharmaceutical Co Ltd maintains only 5.37% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Hubei Guangji Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Hubei Guangji Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Merck & Company Inc
NYSE:MRK |
Drug Manufacturers - General | 0.22% |
|
AstraZeneca PLC
NASDAQ:AZN |
Drug Manufacturers - General | 0.10% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.33% |
|
Novartis AG
MX:NVSN |
Drug Manufacturers - General | 0.08% |
|
Pfizer Inc
NYSE:PFE |
Drug Manufacturers - General | 5.33% |
|
Novo Nordisk A/S
CO:NOVO-B |
Drug Manufacturers - General | 0.09% |
|
Zhejiang Int'L Group Co Ltd
SHE:000411 |
Drug Manufacturers - General | 0.00% |
|
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR |
Drug Manufacturers - General | 0.07% |
Hubei Guangji Pharmaceutical Co Ltd Asset Resilience Ratio by Year (1999–2011)
Hubei Guangji Pharmaceutical Co Ltd asset resilience ratio by year from 1999 to 2011. The table below shows the annual Asset Resilience Ratio data for Hubei Guangji Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2011-12-31 | 0.00% | CN¥42.25K ≈ $6.18K |
CN¥1.51 Billion ≈ $220.47 Million |
-1.33pp |
| 2006-12-31 | 1.34% | CN¥10.50 Million ≈ $1.54 Million |
CN¥785.02 Million ≈ $114.87 Million |
+0.20pp |
| 2005-12-31 | 1.13% | CN¥10.00 Million ≈ $1.46 Million |
CN¥882.44 Million ≈ $129.13 Million |
+0.04pp |
| 2004-12-31 | 1.10% | CN¥10.00 Million ≈ $1.46 Million |
CN¥911.95 Million ≈ $133.45 Million |
-0.17pp |
| 2003-12-31 | 1.27% | CN¥11.00 Million ≈ $1.61 Million |
CN¥866.94 Million ≈ $126.86 Million |
-2.43pp |
| 2000-12-31 | 3.70% | CN¥25.00 Million ≈ $3.66 Million |
CN¥676.22 Million ≈ $98.95 Million |
-0.93pp |
| 1999-12-31 | 4.62% | CN¥30.00 Million ≈ $4.39 Million |
CN¥648.78 Million ≈ $94.94 Million |
-- |
About Hubei Guangji Pharmaceutical Co Ltd
Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, pharmaceutical preparations, and feed additives in China and internationally. The company also exports its products. Hubei Guangji Pharmaceutical Co., Ltd. was founded in 1969 and is based in Wuxue, China.